X

Trial Profile

Linezolid vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 02 Aug 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Linezolid (Primary) ; Cefazolin; Gentamicin; Vancomycin
Indications Bacteraemia; Catheter infections; Gram-positive infections
Focus Therapeutic Use
Sponsors Pfizer

Most Recent Events

31 Jul 2022 This trial has been completed in Slovakia (End Date: 18 Sep 2006), according to European Clinical Trials Database record.
11 Apr 2022 This trial has been completed in Spain (End Date: 18 Sep 2006), according to European Clinical Trials Database record.
28 Sep 2008 Planned end date (Sep 2006) added as reported by CT.gov

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com